Drug-coated balloons in primary percutaneous coronary intervention for acute myocardial infarction

doi:10.3969/j.issn.1006-7795.2023.04.025

Abstract

Abstract: Objective This study was to evaluate the efficacy of drug-coated balloons(DCB) for acute myocardial infarction (AMI).Methods A total of 75 AMI patients who underwent primary percutaneous coronary intervention(PCI)with DCB treatment of culprit lesion in Beijing Friendship Hospital, Capital Medical University, from August 2018 to July 2022 were enrolled in this study. The clinical data, characteristics of coronary artery lesion and prognosis were retrospectively analyzed.Results The procedural success rate was 100%, and the incidence of clinical adverse events in hospitalization was 8%. During the 30-day follow-up, 2 patients (2.7%) were readmitted for heart failure. During a median follow-up of 16 months, there were 9 cases (12%) of non-fatal myocardial infarction, 5 cases (6.7%) of target lesion revascularization, 4 cases (5.3%) of heart failure readmission, and 3 cases (4%) of stroke. The long-term cumulative main adverse cardiovascular and cerebrovascular events (MACCE) rate was 24%, and the Kaplan-Meier estimated long-term MACCE-free survival rate was 63.6%（47.3%-79.8%）. Conclusions For specific lesions in AMI, such as in-stent occlusion, small vessel disease and bifurcation lesions, DCB angioplasty in primary PCI has a high success rate and a good long-term prognosis.

Key words: drug-coated balloon, acute myocardial infarction, percutaneous coronary intervention

CLC Number:

Zhou Li, Zhu Chao, Wang Fucai, Cui Hehe, Liu Qingbo, Zhao Huiqiang, Chen Hui. Drug-coated balloons in primary percutaneous coronary intervention for acute myocardial infarction[J]. Journal of Capital Medical University, 2023, 44(4): 669-675.

References

［1］陈韵岱, 王建安, 刘斌, 等. 药物涂层球囊临床应用中国专家共识［J］. 中国介入心脏病学杂志, 2016, 24(2): 61-67.
［2］ Jeger R V, Eccleshall S, Wan Ahmad W A, et al. Drug-coated balloons for coronary artery disease: third report of the International DCB Consensus Group［J］. JACC Cardiovasc Interv, 2020, 13(12): 1391-1402.
［3］ Nakazawa G, Finn A V, Joner M, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study［J］. Circulation, 2008, 118(11): 1138-1145.
［4］ Gonzalo N, Barlis P, Serruys P W, et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography［J］. JACC Cardiovasc Interv, 2009, 2(5): 445-452.
［5］ Fang C Y, Fang H Y, Chen C J, et al. Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study［J］. PeerJ, 2018, 6: e4646.
［6］ Vos N S, Dirksen M T, Vink M A, et al. Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study［J］. EuroIntervention, 2014, 10(5): 584-590.
［7］ Vos N S, Fagel N D, Amoroso G, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial［J］. JACC Cardiovasc Interv, 2019, 12(17): 1691-1699.
［8］许骥, 华琦, 胡少东, 等. 替格瑞洛在老年STEMI患者急诊PCI中的疗效与安全性分析［J］. 首都医科大学学报, 2015, 36(1): 73-77.
［9］ Gibson C M, De Lemos J A, Murphy S A, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy［J］. Circulation, 2001, 103(21): 2550-2554.
［10］ Neumann F J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)［J］. G Ital Cardiol (Rome), 2019, 20(7/8 Suppl 1): 1S-61S.
［11］ De Luca G, Suryapranata H, Stone G W, et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials［J］. Int J Cardiol, 2008, 126(1): 37-44.
［12］ Scheller B, Ohlow M A, Ewen S, et al. Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial［J］. EuroIntervention, 2020, 15(17): 1527-1533.
［13］ Stefanini G G, Alfonso F, Barbato E, et al. Management of myocardial revascularisation failure: an expert consensus document of the EAPCI［J］. EuroIntervention, 2020, 16(11): e875-e890.
［14］ Joner M, Koppara T, Byrne R A, et al. Neoatherosclerosis in patients with coronary stent thrombosis: findings from optical coherence tomography imaging (a report of the PRESTIGE consortium)［J］. JACC Cardiovasc Interv, 2018, 11(14): 1340-1350.
［15］ Enomoto S, Kuramitsu S, Shinozaki T, et al. Risk factors and outcomes of recurrent drug-eluting stent thrombosis: insights from the REAL-ST registry［J］. J Am Heart Assoc, 2021, 10(9): e018972.
［16］ Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)［J］. Eur Heart J, 2018, 39(2): 119-177.
［17］ Zhang Y X, Zhang X Y, Dong Q C, et al. Duration of dual antiplatelet therapy after implantation of drug-coated balloon［J］. Front Cardiovasc Med, 2021, 8: 762391.

[1]	Zhang Xiaowen, Tang Tao, Li Di, Li Shen, Xi Chunjiang. Analysis of the risk factors of the infarct growth rate in acute anterior circulation large vessel occlusion [J]. Journal of Capital Medical University, 2025, 46(4): 688-693.
[2]	Jiang Xue, Yu Panpan, Zeng Xiangjun, Guo Caixia. The effect of soluble receptor for advanced glycation end products on protein changes and function in cardiac ischemia-reperfusion based on proteomics [J]. Journal of Capital Medical University, 2025, 46(3): 503-510.
[3]	Jiao Jian, Wang Xiaoqi, Shao Feng, Yuan Dan, Li Zhongxin . A study on the correlation between serum visfatin and coronary artery calcification in maintenance hemodialysis patients [J]. Journal of Capital Medical University, 2024, 45(6): 1095-1099.
[4]	Hou Dongyan, Feng Dan, Li Na. Efficacy of dapagliflozin in treatment of coronary heart disease and heart failure with preserved ejection fraction patients [J]. Journal of Capital Medical University, 2024, 45(4): 715-720.
[5]	Dong Zheng, Yang Qingmiao, Guo Caixia. Effect of stress hyperglycemic ratio on poor in-hospital prognosis in patients with acute myocardial infarction [J]. Journal of Capital Medical University, 2024, 45(3): 494-500.
[6]	Zhang Jun, Li Jie, Wang Jing, Hua Lin, Zhang Liming. Clinical analysis of eosinophilic granulomatosis with polyangiitis in elderly patientsZhang Jun1， Li Jie1， Wang Jing1， Hua Lin2, Zhang Liming1* [J]. Journal of Capital Medical University, 2024, 45(3): 515-523.
[7]	Tuo Lin, Bao Xiaoyuan. A risk model to predict the in-hospital mortality of subarachnoid hemorrhage [J]. Journal of Capital Medical University, 2024, 45(2): 348-355.
[8]	Wang Yiwen, Li Chenglong, Hou Xiaotong. Severity classification of post-cardiotomy cardiogenic shock [J]. Journal of Capital Medical University, 2024, 45(2): 363-370.
[9]	Li Lina, Yang Minfu. Current status and prospect of cardiovascular fibroblast imaging [J]. Journal of Capital Medical University, 2024, 45(1): 46-51.
[10]	Ma Wei, Zhou Yifan, Jiang Huimin, Wei Huimin, Zhou Chen, Ji Xunming. Research progresses in cerebral venous sinus thrombosis animal models [J]. Journal of Capital Medical University, 2023, 44(5): 704-714.
[11]	Feng Dan, Li Na, Hou Dongyan. Correlation between residual lipoprotein cholesterol and acute myocardial infarction [J]. Journal of Capital Medical University, 2023, 44(5): 872-876.
[12]	He Sha, Yuan Mengwei, Gao Yan, Gou Dongyun, Li Yang, Qiu Huiqing. Association between ApoE gene polymorphism and cardiovascular and cerebrovascular diseases in Hebei Han nationality [J]. Journal of Capital Medical University, 2023, 44(5): 852-858.
[13]	Gao Xia, Hu Yanjin, Yao Zhi, Wang Guang. Correlation between triglyceride glucose index and severity of coronary artery disease in patients with newly diagnosed coronary heart disease [J]. Journal of Capital Medical University, 2023, 44(3): 381-386.
[14]	Wei Ying, Wang Guang. Higher hemoglobin glycation index is associated with higher risk of carotid plaques [J]. Journal of Capital Medical University, 2023, 44(3): 387-392.
[15]	Li Jie, Zhang Jun, Wang Jing, Hua Lin, Zhang Liming. Clinical analysis of renal involvement in eosinophilic granulomatosis with polyangiitis [J]. Journal of Capital Medical University, 2023, 44(3): 494-500.